New conceptions in the mechanism of action of fibrates and prospective therapeutics in atherosclerosis;Nouvelles conceptions sur le mode d'action des fibrates et prospectives thérapeutiques de l'athérosclérose

Bulletin de l'Academie Nationale de Medecine

Volumn 185, Issue 1, 2001, Pages 63-74

  Fruchart, Jean Charles ^a   Staels, Bart ^b   Duriez, Patrick ^b  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL; ARTERIOSCLEROSIS; DRUG EFFECT; HUMAN; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSIOLOGY; REVIEW;

ANIMALS; ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; HUMANS; OBESITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0035236033     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)34590-x     Document Type: Article

References (20)

1. ISSEMANN I., GREEN S. - Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 1990, 347, 645-650.
2. A unified nomenclature system for the nuclear receptor superfamily. Cell, 1999, 97, 161-163.
3. SHER T., YI H.F., MCBRIDE O.W., GONZALEZ F.J. - cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry, 1993, 32, 5598-5604.
4. ROBERTS R.A., JAMES N.H., WOODYATT N.J., MACDONALD N., TUGWOOD J.D. - Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor α. Carcinogenesis, 1998, 19, 43-48.
5. GÖTTLICHER M., WIDMARK E., LI Q., GUSTAFSSON J.A. - Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci USA, 1992, 89, 4653-4657.
6. FRUCHART J.C., DURIEZ P., STAELS B. - PPARα activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Current Opinion in Lipidology, 1999, 10, 245-257.
7. STAELS B., VU-DAC N., KOSYKH V.A., SALADIN R., FRUCHART J.C., DALLONGEVILLE J., AUWERX J. - Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates. J Clin Invest, 1995, 95, 705-712.
8. VU-DAC N., SCHOONJANS K., LAINE B., FRUCHART J.C., AUWERX J., STAELS B. - Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J Biol Chem, 1994, 269/49, 31012-31018.
9. VU-DAC N., SCHOONJANS K., KOSYKH V., DALLONGEVILLE J., FRUCHART J.C., STAELS B., AUWERX J. - Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J Clin Invest, 1995, 96, 741-750.
10. DELERIVE P., DE BOSSCHER K., BESNARD S., VANDEN BERGHE W., PETERS J.M., GONZALEZ F.J., FRUCHART J.C., TEDGUI A., HAEGEMAN G., STAELS B. - PPARα negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1. J Biol Chem. 1999, 274, 32048-32054.
11. DELERIVE P., GERVOIS P., FRUCHART J.C., STAELS B. - Induction of Ikappa B alpha expression as a mechanism contributing to the anti-inflammatory activities of PPARalpha activators. J Biol Chem, 2000, 275, 36703-36707.
12. STAELS B., KOENIG W., HABIB A., MERVAL R., LEBRET M., PINEDA TORRA I., DELERIVE P., FADEL A., CHINETTI G., FRUCHART J.C., NAJIB J., MACLOUF J., TEDGUI A. - Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators. Nature, 1998, 393, 790-793.
13. CHINETTI G., GBAGUIDI F.G., GRIGLIO S., MALLAT Z., ANTONUCCI M., POULAIN P., CHAPMAN J., FRUCHART J.C., TEDGUI A., NAJIB-FRUCHART J., STAELS B. - CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation, 2000, 101, 2411-2417.
14. CHINETTI G., LESTAVEL S., BOCHER V., REMALEY A.T., NEVE B., TORRA PINEDA I., TEISSIER E., MINNICH A., JAYE M., DUVERGER N., BREWER H.B., FRUCHART J.C., CLAVEY V., STAELS B. -PPARα and PPARγ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med, 2001, 7, 53-58.
15. DELERIVE P., MARTIN-NIZARD F., CHINKTTI G., TROTTEIN F., FRUCHART J.C., NAJIB J., DURIEZ P., STAELS B. - PPAR activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circ Res, 1999, 85, 394-402.
16. NEVE B., CORSEAUX D., CHINETTI G., ZAWADZKI C., FRUCHART J.C., DURIEZ P., STAELS B., JUDE B. - PPARα agonists inhibit tissue factor expression in human THP-1 cells, monocytes and macrophages. Circulation, 2001, 103, 207-212.
17. DELERIVE P., FURMAN C., TEISSIER E., FRUCHART J.C., DURIEZ P., STAELS B. - Oxidized phospholipids activate PPARα in a phospholipase A2-dependent manner. FEBS Lett, 2000, 471, 34-38.
18. GUERRE-MILLO M., GERVOIS P., RASPE E., MADSEN L., POULAIN P., DERUDAS B., HERBERT J.M., WINEGAR D.A., WILLSON T.M., FRUCHART J.C., BERGE R.K., STAELS, B. - PPARα activators improve insulin sensitivity and reduce adiposity. J Biol Chem, 2000, 275, 16638-16642.
19. FLAVELL D.M., PINEDA TORRA I., JAMSHIDI Y., EVANS D., DIAMOND J.R., ELKELES R.S., BUJAC S.R., MILLER G., TALMUD P.J., STAELS B., HUMPHRIES S.E. - Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in type II diabetic subjects. Diahetologia, 2000, 43, 673-680.
20. LACQUEMANT C., LEPRETRE F., PINEDA TORRA I., MANRAJ M., CHARPENTIER G., RUIZ J., STAELS B., FROGUEL P. - Mutation screening of the PPARalpha gene in type 2 diabetes associated with coronary heart disease. Diabetes Metab, 2000, 26, 393-401.